- Home
- PRME vs AC Comparison
PRME vs AC Comparison
Compare PRME & AC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- AC
- Stock Information
- Founded
- PRME 2019
- AC 1976
- Country
- PRME United States
- AC United States
- Employees
- PRME N/A
- AC N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- AC Investment Bankers/Brokers/Service
- Sector
- PRME Health Care
- AC Finance
- Exchange
- PRME Nasdaq
- AC Nasdaq
- Market Cap
- PRME 424.9M
- AC 753.2M
- IPO Year
- PRME 2022
- AC N/A
- Fundamental
- Price
- PRME $3.80
- AC $40.79
- Analyst Decision
- PRME Strong Buy
- AC
- Analyst Count
- PRME 8
- AC 0
- Target Price
- PRME $14.14
- AC N/A
- AVG Volume (30 Days)
- PRME 3.0M
- AC 6.2K
- Earning Date
- PRME 11-01-2024
- AC 11-06-2024
- Dividend Yield
- PRME N/A
- AC 0.24%
- EPS Growth
- PRME N/A
- AC 85.41
- EPS
- PRME N/A
- AC 1.54
- Revenue
- PRME $591,000.00
- AC $13,442,000.00
- Revenue This Year
- PRME N/A
- AC N/A
- Revenue Next Year
- PRME N/A
- AC N/A
- P/E Ratio
- PRME N/A
- AC $25.13
- Revenue Growth
- PRME N/A
- AC N/A
- 52 Week Low
- PRME $3.28
- AC $28.58
- 52 Week High
- PRME $9.86
- AC $41.45
- Technical
- Relative Strength Index (RSI)
- PRME 50.60
- AC 89.93
- Support Level
- PRME $3.45
- AC $37.06
- Resistance Level
- PRME $4.03
- AC $37.15
- Average True Range (ATR)
- PRME 0.33
- AC 0.96
- MACD
- PRME 0.06
- AC 0.40
- Stochastic Oscillator
- PRME 29.89
- AC 90.29
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About AC Associated Capital Group Inc.
Associated Capital Group Inc is a diversified global financial services company. It operates in the business of alternative investment management, institutional research services, and cash and other assets through subsidiaries. The activities of its subsidiaries comprise publishing daily research notes and full reports using private market value with a catalyst methodology and also products and customized solutions utilizing private market value with catalyst method of investing.